ImmuPharma PLC (LSE: IMM), the specialist drug discovery and development company is pleased to provide an update on ongoing activities.
Tim McCarthy , Non-Executive Chairman of ImmuPharma (AIM:IMM) Interview
ImmuPharma focuses on developing pioneering and novel drugs in specialist therapeutic areas
Shard Capital: Insights into the small pharmaceutical company sector (video)
Wealth Manager at Shard Capital Stockbrokers, Simon Niven, provides some insights into the small pharmaceutical company sector.
